Urinary extracellular matrix proteins as predictors of the severity of ureteropelvic junction obstruction in children

被引:1
|
作者
Mello, Marcos Figueiredo [1 ]
dos Reis, Sabrina Thalita [2 ]
Kondo, Enzo Yagi [2 ]
de Bessa Junior, Jose [3 ]
Denes, Francisco Tibor [1 ]
Lopes, Roberto Iglesias [1 ]
机构
[1] Univ Sao Paulo, Hosp Clin, Div Urol, Pediat Urol Unit,Med Sch, Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Lab Med Invest LIM 55, Med Sch, Sao Paulo, SP, Brazil
[3] Univ Estadual Feira de Santana, Div Urol, Pediat Urol Unit, Feira De Santana, BA, Brazil
基金
巴西圣保罗研究基金会;
关键词
Ureteropelvic junction obstruction; Urinary markers; Metalloproteinases; Children; TISSUE INHIBITOR; METALLOPROTEINASES; HYDRONEPHROSIS; MANAGEMENT; EXPRESSION; FIBROSIS; TIMP-2;
D O I
10.1016/j.jpurol.2021.03.017
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction Ureteropelvic junction obstruction (UPJO) particu-larly represents a challenge in regard to manage-ment, as not all hydronephrosis (HN) represent a kidney-damaging state. Urinary biomarkers have been proposed as noninvasive tools. Extracellular matrix (ECM) proteins are associated with tissue fibrosis in the setting of UPJO and is poorly explored. Objective To investigate whether urinary ECM proteins are useful to discriminate the severity of urinary obstruction on unilateral UPJO. Study design Children with unilateral UPJO were prospective enrolled. Urinary (u) matrix metalloproteinases (MMP-1,-2,-9 and TIMP-1,-2) as well as clinical characteristics were measured in the following groups: 26 children with obstructive HN at initial diagnosis and after six months of dismembered pyeloplasty; 22 children with non-obstructive HN at diagnosis and after six months of observation; 26 children without any urinary tract condition, as the control group. Results were assessed statistically using for homogenous groups, a one-way analysis of variances (ANOVA) and for nonparametric groups, Mann-Whitney test or Kruskal-Wallis test was per -formed. ROC curves were performed. Results Baseline samples demonstrated a higher concentra-tion of uMMP-1/Cr, uMMP-2/Cr, u-TIMP-1/Cr and u-TIMP-2/Cr in obstructive HN group; uMMP-9/Cr levels were higher in non-obstructive HN group and all studied biomarkers had lower concentrations for the control group. On follow-up, for the obstructive HN group, urinary concentration of uTIMP-1/Cr and uTIMP-2/Cr decreased, and uMMP-1/Cr, uMMP-2/Cr and uMMP-9/Cr increased when comparing preop-erative to postoperative values. In the non-obstructive HN group, all proteins analyzed were stable after six months of observation. ROC curves analysis showed a promising diagnostic profile for the detection of obstructive HN for uTIMP-1/Cr (area under the curve-AUC-; of 0.692), uTIMP-2/Cr (AUC of 0.678) and for uMMP-2/Cr (AUC of 0.655). Discussion The severity of kidney obstruction could correlate with the urinary ECM proteins concentration in this study. This is concordant with prior studies demon-strating that a disruption of the balance of accu-mulation/degradation of the ECM proteins occur on obstructive uropathy. Limitations of our study include the older age of our patients and that these markers had no influence at all on the surgical decision. Conclusion We demonstrate that obstructive HN have signifi-cantly higher uMMP-2, uTIMP-1 and uTIMP-2 con-centrations. Particularly, uTIMP-2 levels were correlated to severity of obstruction and therefore, it might be a useful urinary biomarker to correctly allocate children with HN between surgical man-agement vs follow-up. After pyeloplasty, uTIMP-1 and uTIMP-2 presented a progressive decrease postoperatively, which is also highly desirable for urinary markers.
引用
收藏
页码:438.e1 / 438.e7
页数:7
相关论文
共 50 条
  • [1] Matrix metalloproteinases in ureteropelvic junction obstruction
    Pavlaki, A.
    Printza, N.
    Farmaki, E.
    Stabouli, S.
    Taparkou, A.
    Dotis, J.
    Papachristou, F.
    HIPPOKRATIA, 2017, 21 (03) : 136 - 139
  • [2] The role of urinary NGAL and serum cystatin C in assessing the severity of ureteropelvic junction obstruction in infants
    Pavlaki, Antigoni
    Printza, Nikoleta
    Farmaki, Evangelia
    Stabouli, Stella
    Taparkou, Anna
    Sterpi, Magdalini
    Dotis, John
    Papachristou, Fotios
    PEDIATRIC NEPHROLOGY, 2020, 35 (01) : 163 - 170
  • [3] The roles of extracellular matrix proteins, apoptosis and c-kit positive cells in the pathogenesis of ureteropelvic junction obstruction
    Ozel, S. K.
    Emir, H.
    Dervisoglu, S.
    Akpolat, N.
    Senel, B.
    Kazez, A.
    Soylet, Y.
    Cetin, G.
    Danismend, N.
    Buyukunal, S. N. C.
    JOURNAL OF PEDIATRIC UROLOGY, 2010, 6 (02) : 125 - 129
  • [4] Comparing accuracy of urinary biomarkers in differentiation of ureteropelvic junction obstruction from nonobstructive dilatation in children
    Sangeetha, Geminiganesan
    Babu, Ramesh
    PEDIATRIC NEPHROLOGY, 2022, 37 (10) : 2277 - 2287
  • [5] Urinary heme oxygenase-1 in children with congenital hydronephrosis due to ureteropelvic junction obstruction
    Li, ZhenZhen
    Liu, XiangHua
    Liu, Shan
    Gu, ChaoHui
    Tian, FengYan
    Wen, JianGuo
    BIOMARKERS, 2012, 17 (05) : 471 - 476
  • [6] Comparing accuracy of urinary biomarkers in differentiation of ureteropelvic junction obstruction from nonobstructive dilatation in children
    Geminiganesan Sangeetha
    Ramesh Babu
    Pediatric Nephrology, 2022, 37 : 2277 - 2287
  • [7] Urinary proteome analysis and the management of ureteropelvic junction obstruction
    Mesrobian, Hrair-George O.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1595 - 1596
  • [8] Urinary proteome analysis and the management of ureteropelvic junction obstruction
    Hrair-George O. Mesrobian
    Pediatric Nephrology, 2010, 25 : 1595 - 1596
  • [9] Stentless pyeloplasty for ureteropelvic junction obstruction in children
    Jan, Iftikhar A.
    Hussain, Mussarat
    Khan, Ejaz
    Aurakzai, Hazrat Ullah
    Hanif, Shahbaz
    ANNALS OF PEDIATRIC SURGERY, 2015, 11 (01): : 18 - 20
  • [10] The role of urinary NGAL and serum cystatin C in assessing the severity of ureteropelvic junction obstruction in infants
    Antigoni Pavlaki
    Nikoleta Printza
    Evangelia Farmaki
    Stella Stabouli
    Anna Taparkou
    Magdalini Sterpi
    John Dotis
    Fotios Papachristou
    Pediatric Nephrology, 2020, 35 : 163 - 170